Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

Related Keywords

Brompton ,Medway ,United Kingdom ,Mexico ,Japan ,Tokyo ,Dubai ,Dubayy ,United Arab Emirates ,Brazil ,Canada ,London ,City Of ,Maryo Brien ,Christopherm Orton ,Fujifilm Toyama Chemical Co ,European Respiratory Society International Congress ,Imperial College ,Fujifilm ,Cellvera Press ,Holdings Corporation ,Health Canada ,Regulation Services Provider ,Guy Chamberland ,Chief Regulatory Officer ,Consultant Respiratory Physician ,Royal Brompton Hospital ,European Respiratory Society International ,Randomised Controlled Trial ,Early Intervention ,Patients Hospitalized ,Erses Standard ,Westminister Hospital ,Westminster Hospital ,Global Response Aid ,Tetra Bio Pharma ,Tetra Bio Pharma Inc ,